SUMMER COLLIER: Open Payments
NPI 1487964235 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 10 payments from 3 companies in 2025. Trend: 2023 $289 · 2024 $504 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 2 | $153 |
| Gilead Sciences, Inc. | 7 | $141 |
| Madrigal Pharmaceuticals | 1 | $118 |
Products named: IQIRVO, REZDIFFRA.
Industry payments across CA — which companies pay providers there.
